We present the case of a 74-year-old male with an 18-year history of IgG kappa multiple myeloma who received multiple lines of treatment, including carfilzomib-dexamethasone every three weeks for the last 8 months.
7
JUN
JUN
0
We present the case of a 74-year-old male with an 18-year history of IgG kappa multiple myeloma who received multiple lines of treatment, including carfilzomib-dexamethasone every three weeks for the last 8 months.